5398 慕康生醫本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/06 | 90.26 | 17.15 |
| 2026/05 | 89.74 | 17.05 |
| 2026/04 | 106.32 | 20.20 |
| 2026/03 | 124.21 | 23.60 |
| 2026/02 | 121.58 | 23.10 |
| 2026/01 | 106.84 | 20.30 |
| 2025/12 | 136.84 | 26.00 |
| 2025/11 | 136.84 | 26.00 |
| 2025/10 | 100.53 | 19.10 |
| 2025/09 | 106.05 | 20.15 |
| 2025/08 | 112.63 | 21.40 |
| 2025/07 | -1137.50 | 22.75 |
| 2025/06 | -1157.50 | 23.15 |
| 2025/05 | -1090.00 | 21.80 |
| 2025/04 | 85.95 | 18.05 |
| 2025/03 | 80.24 | 16.85 |
| 2025/02 | 88.33 | 18.55 |
| 2025/01 | -877.50 | 17.55 |
| 2024/12 | -972.50 | 19.45 |
| 2024/11 | -1147.50 | 22.95 |
| 2024/10 | -118.82 | 20.20 |
| 2024/09 | -108.24 | 18.40 |
| 2024/08 | -107.35 | 18.25 |
| 2024/07 | -50.94 | 16.30 |
| 2024/06 | -60.47 | 19.35 |
| 2024/05 | -53.13 | 17.00 |
| 2024/04 | -26.88 | 17.20 |
| 2024/03 | -28.44 | 18.20 |
| 2024/02 | -30.31 | 19.40 |
| 2024/01 | -38.46 | 20.00 |
| 2023/12 | -29.33 | 15.25 |
| 2023/11 | -25.58 | 13.30 |
| 2023/10 | -25.81 | 11.10 |
| 2023/09 | -28.60 | 12.30 |
| 2023/08 | -30.23 | 13.00 |
| 2023/07 | -39.71 | 13.50 |
| 2023/06 | -43.82 | 14.90 |
| 2023/05 | -46.76 | 15.90 |
| 2023/04 | -116.43 | 16.30 |
| 2023/03 | -116.07 | 16.25 |
| 2023/02 | -119.29 | 16.70 |
| 2023/01 | -266.67 | 16.00 |
| 2022/12 | -273.33 | 16.40 |
| 2022/11 | -285.00 | 17.10 |
| 2022/10 | -426.25 | 17.05 |
| 2022/09 | -431.25 | 17.25 |
| 2022/08 | -473.75 | 18.95 |
| 2022/07 | 211.88 | 16.95 |
| 2022/06 | 231.25 | 18.50 |
| 2022/05 | 248.75 | 19.90 |
| 2022/04 | 64.09 | 21.15 |
| 2022/03 | - | - |
| 2022/02 | 58.79 | 19.40 |
| 2022/01 | 32.02 | 19.85 |
| 2021/12 | 32.66 | 20.25 |
| 2021/11 | 31.13 | 19.30 |
| 2021/10 | 33.50 | 20.10 |
| 2021/09 | 33.50 | 20.10 |
| 2021/08 | 33.33 | 20.00 |
| 2021/07 | 48.84 | 21.00 |
| 2021/06 | 41.86 | 18.00 |
| 2021/05 | 43.95 | 18.90 |
| 2021/04 | 58.68 | 19.95 |
| 2021/03 | 57.06 | 19.40 |
| 2021/02 | 56.91 | 19.35 |
| 2021/01 | - | 19.50 |